Approval · Notice of Compliance 115 · 2004
ELIGARD: Notice of Compliance 115
Issued February 23, 2004
A Notice of Compliance is Health Canada’s approval of a drug submission: a new drug, a new use or form, or a change to an approved one. The product itself is in the Drug Product Database, with its current status.
- Notice number
- 115
- Date
- February 23, 2004
- Company
- Sanofi-Synthelabo Canada Inc.Laval, Quebec, Canada
- Product type
- Prescription Pharmaceutical
- Submission
- Supplement to a New Drug Submission (SNDS), supplement
- Submission class
- Other
- Reason
- New strength: 30mg
- Therapeutic class
- Luteinizing hormone-releasing hormone agonist analog
Products in this notice
| Brand | DIN | Status today |
|---|---|---|
| ELIGARD | 02248999 | Marketed |
Medicinal ingredients
- LEUPROLIDE ACETATE 35.8 MG per SYR